Ingrid Verhaart

6PUBLICATIONS
6CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsBiologically active moleculesGenetically modified animalsGene and molecular therapyClinical nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 27, 2023
Challenges of Assessing Exon 53 Skipping of the Human <i>DMD</i> Transcript with Locked Nucleic Acid-Modified Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy.

Sarah Engelbeen, Daniel O'Reilly, Davy Van De Vijver

|Dec 01, 2021
7',5'-alpha-bicyclo-DNA: new chemistry for oligonucleotide exon splicing modulation therapy.

Damien Evéquoz, Ingrid E C Verhaart, Davy van de Vijver

|Aug 21, 2019
Cross-sectional study into age-related pathology of mouse models for limb girdle muscular dystrophy types 2D and 2F.

Ingrid E C Verhaart, Kayleigh Putker, Davy van de Vijver

|Jun 01, 2019
Therapeutic developments for Duchenne muscular dystrophy.

Ingrid E C Verhaart, Annemieke Aartsma-Rus

|Apr 25, 2019
A modified diet does not ameliorate muscle pathology in a mouse model for Duchenne muscular dystrophy.

Ingrid E C Verhaart, Davy van de Vijver, Joke W Boertje-van der Meulen

|Jun 22, 2017
A multi-source approach to determine SMA incidence and research ready population.

Ingrid E C Verhaart, Agata Robertson, Rebecca Leary

Pageof 1

Frequent Collaborators

3 joint publications

Annemieke Aartsma-Rus

1 joint publications

Hanns Lochmüller

1 joint publications

Jaap J Plomp

1 joint publications

Damien Evéquoz